Role of arachidonic acid metabolites on the control ofnon-differentiated intestinal epithelial cell growth

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1620-1628

  Cabral, Marisol ^a   Martín Venegas, Raquel ^a   Moreno, Juan J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cell signaling; Colorectal cancer; Hydroxyeicosatetraenoic acid; Leukotriene; Prostaglandin

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; DNA; EPOXYICOSATRIENOIC ACID; LEUKOTRIENE B4; PROSTAGLANDIN E2;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; INTESTINE EPITHELIUM CELL; METABOLITE; SIGNAL TRANSDUCTION;

EID: 84884879870     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.05.009     Document Type: Article

References (44)

1. Barnett J, Chow J, Ives D, Chiou M, Mac Kenzie R, Osen E, et al. Purification, charac-terization and selective inhibition of human prostaglandin G/H synthase 1 and 2expressed in the baculovirus system. Biochimica et Biophysica Acta 1994;1209:130-9.. (Pubitemid 24352000)
2. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL. 5-Lipoxygenase inhibitoryactivity of zileuton. Journal of Pharmacology and Experimental Therapeutics 1991;256:929-37..
3. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2promotes colon cancer cell growth through a Gα-axin- β-catenin signalling axis. Science 2005;310:1504-10.. (Pubitemid 41746348)
4. Cherukuri DP, Chen XBO, Goulet AC, Young RN, Han Y, Heimark RL, et al. The EP4receptor antagonist, L-161, 982, blocks prostaglandin E2-induced signal trans-duction and cell proliferation in HCA-7 colon cancer cells. Experimental Cell Research 2007;313:2969-79.. (Pubitemid 47125887)
5. Cianchi F, Cortesini C, Magnelli L, Fanti E, Papucci L, Schiavone N, et al. Inhibitionof 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib inhuman colon cancer cells. Molecular Cancer Therapeutics 2006;5:2716-26.. (Pubitemid 44848998)
6. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, et al. Require-ment of a 5-lipoxygenase-activanting protein for leukotriene synthesis. Nature 1990;343:282-4..
7. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. Apopulation-based study. New England Journal of Medicine 1999;323:1228-33..
8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomasand adeno carcinomas. Gastroenterology 1994;107:1183-8.. (Pubitemid 24294584)
9. Ferrer R, Moreno JJ. Role of eicosanoids on intestinal epithelial homeostasis. Bio-chemical Pharmacology 2010;80:431-8..
10. Funk CD, Furci L, Fitzgerald GA, Grygorczk R, Rochette C, Bayne MA, et al. Cloningand expression of a cDNA for the human prostaglandin E receptor EP1 subtype. Journal of Biological Chemistry 1993;268:26767-72.. (Pubitemid 23361766)
11. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treat-ment of colonic and rectal adenomas with sulindac in familial adenomatouspolyposis. New England Journal of Medicine 1993;328:1313-6.. (Pubitemid 23131373)
12. Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G. COX-2 independentinduction of cell cycle arrest and apoptosis in colon cancer cells by the selectiveCOX-2 inhibitor celecoxib. FASEB Journal 2001;15:2742-4..
13. Ihara A, Wada K, Yoneda M, Fijisawa N, Takahashi H, Nakajima A. Blockade ofleukotriene B4signaling pathway induces apoptosis and suppresses cell pro-liferation in colon cancer. Journal of Pharmacological Sciences 2007;103:24-32.. (Pubitemid 46175592)
14. Iizuka Y, Okuno T, Saeki K, Uozaki H, Okada S, Misaka T, et al. Protective role ofthe leukotriene B4receptor BLT2in murine inflammatory colitis. FASEB Journal 2010;24:4678-90..
15. Kamitani H, Geller M, Eling T. Expression of 15-lipoxygenase by human colorec-tal carcinoma Caco-2 cells during apoptosis and cell differentiation. Journal ofBiological Chemistry 1998;73:21569-77.. (Pubitemid 28405326)
16. Kim GY, Lee JW, Cho SH, Seo JM, Kim JH. Role of the low-affinity leukotrienen B4receptor BLT2in VEGF-induced angiogenesis. Arteriosclerosis, Thrombosis, andVascular Biology 2009;29:915-20..
17. Martin-Venegas R, Roig-Perez S, Ferrer R, Moreno JJ. Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation. Journal of Lipid Research 2006;46:1416-23.. (Pubitemid 44079895)
18. Martin-Venegas R, Casillas R, Jáuregui O, Moreno JJ. Rapid simultaneous analysis ofcyclooxygenase, lipoxygenase and cytochrome P-450 metabolites of arachidonicand linoleic acids using high performance liquid chromatography/mass spec-trometry in tandem mode. Journal of Pharmaceutical and Biomedical Analysis 2011;56:976-82..
19. Melstrom LG, Bentrem DJ, Salabat MR, Kennedy TJ, Ding XZ, Strouch M, et al. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effectof 5-LOX inhibitors in vitro and in a murine model. Clinical Cancer Research 2008;14:6525-30..
20. Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE, et al. Chemo-prevention of colon and small intestinal tumorigenesis in APC (Min/+) mice bylicofelone, a novel dual 5-LOX/COX inhibitor: potential implications for humancolon cancer prevention. Cancer Prevention Research 2011;4:2015-26..
21. Moreno JJ. New aspects of the role of hydroxyeicosatetraenoic acids in cell growthand cancer development. Biochemical Pharmacology 2009;77:1-10..
22. Natarajan R, Reddy MA. HETEs/EETs in renal glomerular and epithelial cell functions. Current Opinion in Pharmacology 2003;3:198-203.. (Pubitemid 36416559)
23. Nishigaki N, Negishi M, Honda A, Sugimoto Y, Namba T, Narumiya S, et al. Identifi-cation of prostaglandin E receptor "EP2" cloned from mastocytoma cells as EP4subtype. FEBS Letters 1995;364:339-41..
24. Paruchuri S, Mezhybovska M, Juhas M, Sjölander A. Endogenous production ofleukotrienen D4 mediates autocrine survival and proliferation via CysLT1 recep-tor signaling in intestinal epithelial cells. Oncogene 2006;25:6660-5.. (Pubitemid 44646193)
25. Pham H, Eibl G, Vincenti R, Chong B, Tai HH, Slice LW. 15-hydroxyprostaglandindehydrogenase suppresses K-Rasv12-dependent tumor formation in Nu/Numice. Molecular Carcinogenesis 2008;47:466-77.. (Pubitemid 351822305)
26. 2+-mediated epithelial barrier disruption through EP1and EP4receptorsin Caco-2 cell monolayers. American Journal of Physiology: Cell Physiology 2010;299:324-34..
27. Sanchez T, Moreno JJ. Ketoprofen S(+) enantiomer inhibits prostaglandin productionand cell growth in 3T6 fibroblast cultures. European Journal of Pharmacology 1999;370:63-7.. (Pubitemid 29168517)
28. Sanchez T, Moreno JJ. Calcium-independent phospholipase A2through arachidonicacid mobilization is involved in Caco-2 cell growth. Journal of Cellular Physiology 2002;193:293-8.. (Pubitemid 35276526)
29. Sekiya K, Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Bio-chemical and Biophysical Research Communications 1982;105:1090-5.. (Pubitemid 13219433)
30. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor acti-vated by a diverse array of extracellular signals. Annual Review of Biochemistry 1999;68:821-61.. (Pubitemid 29449210)
31. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, et al. Decreased13-S-hydroxyoctadecadenoic acid levels and 15-lipoxygenase-1 expression inhuman colon cancers. Carcinogenesis 1999;20:1985-95.. (Pubitemid 29476127)
32. Shureiqi I, Lippman SM. Lipoxygenase modulation to reverse carcinogenesis. Cancer Research 2001;61:6307-12.. (Pubitemid 32783228)
33. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, et al. The critical roleof 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Research 2005;65:11486-92.. (Pubitemid 41821706)
34. Shureiqi I, Chen D, Day RS, Zuo X, Hochman FL, Ross WA, et al. Profiling lipoxyge-nase metabolism in specific steps of colorectal tumorigenesis. Cancer Prevention Research 2010;3:829-38..
35. Siu YT, Jin DY. CREB a real culprit in oncogenesis. FEBS Journal 2007;274:3224-32..
36. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, et al. Phar-macological analysis of cyclooxygenase-1 in inflammation. Proceedings of theNational Academy of Sciences of the United States of America 1998;95:13313-8..
37. Sugimoto Y, Narumiya S. Prostaglandin E receptors. Journal of Biological Chemistry 2007;282:11613-7.. (Pubitemid 47100657)
38. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators ofcell survival and apoptosis. Proceedings of the National Academy of Sciences ofthe United States of America 1996;93:5241-6.. (Pubitemid 26159433)
39. Tessner TG, Muhale F, Riehl TE, Anant S, Stenson WF. Prostaglandin E2reduces radiation-induced epithelial apoptosis through a mechanism involv-ing AKT activation and bax translocation. Journal of Clinical Investigation 2004;114:1676-85.. (Pubitemid 40385559)
40. Thun MJ, Namboodiri MM Jr, Health CW. Aspirin use and reduced risk of fatal coloncancer. New England Journal of Medicine 1991;325:1593-6..
41. Wachtershauser A, Steinhilber D, Loitsch SM, Stein J. Expression of 5-lipoxygenaseby human colorectal carcinoma Caco-2 cells during butyrate-inducedcell differentiation. Biochemical and Biophysical Research Communications 2000;268:778-83.. (Pubitemid 30150868)
42. Yamane M, Shimizu S, Abe A, Yamane S. Docosahexaenoic/arachidonic acid ω-hydroxylation system and differentiation in the human colonic adenocarcinomacell line, Caco-2. Cancer Letters 1998;122:51-9.. (Pubitemid 28058617)
43. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. A second leukotriene B4recep-tor, BLT2: a new therapeutic target in inflammation and immunological diseases. Journal of Experimental Medicine 2000;192:421-31.. (Pubitemid 30629167)
44. Yokomizo T, Kato K, Hagiya H, Izumi T, Shimizu T. Hydroxyeicosanoids bind toand activate the low affinity leukotriene B4receptor, BLT2. Journal of Biological Chemistry 2001;276:12454-9..